Quick Answer
BrightSpring Health Services, Inc. reported Cash and Equivalents of $88.37 million for fiscal year 2025.
BrightSpring Health Services, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $88.37M | +45.0% |
| 2024 | $60.95M | +366.3% |
| 2023 | $13.07M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $140.34M | +290.1% | +100.3% |
| June 30, 2025 | $70.07M | +180.0% | +33.9% |
| March 31, 2025 | $52.34M | -9.8% | -14.1% |
| December 31, 2024 | $60.95M | +366.3% | +69.4% |
| September 30, 2024 | $35.97M | — | +43.7% |
| June 30, 2024 | $25.03M | — | -56.9% |
| March 31, 2024 | $58.04M | — | +344.0% |
| December 31, 2023 | $13.07M | — | — |
- BrightSpring Health Services, Inc. showed an increase of +45.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, BrightSpring Health Services, Inc.’s cash and equivalents has grown by 576.1% (from $13.07 million to $88.37 million).
- The most recent figure is from BrightSpring Health Services, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: